(19)
(11) EP 4 815 951 A1

(12)

(43) Date of publication:
07.10.2026 Bulletin 2026/41

(21) Application number: 24827180.1

(22) Date of filing: 02.12.2024
(51) International Patent Classification (IPC): 
A61K 31/496(2006.01)
A61P 25/18(2006.01)
(52) Cooperative Patent Classification (CPC):
A61K 31/496; A61P 25/18
(86) International application number:
PCT/IB2024/062091
(87) International publication number:
WO 2025/120480 (12.06.2025 Gazette 2025/24)
(84) Designated Contracting States:
AL AT BE BG CH CY CZ DE DK EE ES FI FR GB GR HR HU IE IS IT LI LT LU LV MC ME MK MT NL NO PL PT RO RS SE SI SK SM TR
Designated Extension States:
BA
Designated Validation States:
GE KH MA MD TN

(30) Priority: 03.12.2023 US 202363605563 P

(71) Applicant: Janssen Pharmaceutica NV
2340 Beerse (BE)

(72) Inventors:
  • BANGERTER, Abigail Sarah
    Titusville, New Jersey 08560 (US)
  • DREVETS, Wayne C.
    San Diego, California 92121 (US)
  • KLEIN, Matthew Ellis
    Titusville, New Jersey 08560 (US)
  • PANDINA, Gahan Julian
    Titusville, New Jersey 08560 (US)
  • VAIRAVAN, Srinivasan
    Titusville, New Jersey 08560 (US)

(74) Representative: Carpmaels & Ransford LLP 
One Southampton Row
London WC1B 5HA
London WC1B 5HA (GB)

   


(54) METHODS FOR TREATING SUBJECTS WITH AUTISM SPECTRUM DISORDER